News from emergo therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 06, 2019, 08:05 ET Emergo Therapeutics announces successful completion of Phase 2a trial

Emergo Therapeutics has successfully completed their Phase 2a trial for their novel candidate norketotifen (NKT). The trial is yet another step...


May 30, 2019, 09:18 ET Emergo Therapeutics Board of Directors Welcomes Jack Bailey, President, GSK Pharmaceuticals USA

Emergo Therapeutics, which continues to accelerate its lead candidate norketotifen through Phase 2 studies, has added another seasoned executive to...